Table 3.
Incidence rate ratio | 95% CI | P value | |
---|---|---|---|
Total opportunistic infections | |||
SLE | 1 (reference) | – | – |
PM/DM | 1.42 | 1.31–1.55 | < 0.001 |
SSc | 0.73 | 0.65–0.85 | < 0.001 |
RA | 0.58 | 0.56–0.61 | < 0.001 |
pSS | 0.56 | 0.53–0.59 | < 0.001 |
Non-herpes zoster opportunistic infections | |||
SLE | 1 (reference) | – | – |
PM/DM | 1.73 | 1.50–1.98 | < 0.001 |
SSc | 0.83 | 0.68–0.99 | 0.035 |
RA | 0.50 | 0.46–0.54 | < 0.001 |
pSS | 0.41 | 0.37–0.45 | < 0.001 |
SLE systemic lupus erythematosus, RA rheumatoid arthritis, pSS primary Sjögren’s syndrome, SSc systemic sclerosis, PM/DM polymyositis/dermatomyositis, CI confidence interval